Results 121 to 130 of about 31,911 (153)

Therapy-related B-cell acute lymphoblastic leukemia after treatment for multiple myeloma. [PDF]

open access: yesAm J Blood Res
Gajendra S   +7 more
europepmc   +1 more source

The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities. [PDF]

open access: yesNutrients
Caserta S   +15 more
europepmc   +1 more source

Characterization of neocentromeric marker chromosome derived from chromosome 11: a rare entity in four patients with acute leukemia. [PDF]

open access: yesChromosome Res
Mendlikova I   +9 more
europepmc   +1 more source

Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL

International Journal of Hematology, 2023
Early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) is generally considered to be a high-risk subtype. We retrospectively analyzed the clinical outcomes of adult patients diagnosed with ETP-ALL or other T-cell ALL (non-ETP T-ALL).
Yasushi Onishi   +2 more
exaly   +3 more sources

Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

Surgical Pathology Clinics, 2013
Discrete diagnostic subtypes of T lymphoblastic leukemia/lymphoma (T-cell acute lymphoblastic leukemia/lymphoma, T-ALL) have historically not been widely recognized. Recently, a novel subset with distinctive immunophenotypic, molecular, and clinical features has been proposed.
Kathy Foucar
exaly   +3 more sources

Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

Current Hematologic Malignancy Reports, 2012
T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma are uncommon disorders classified together by the World Health Organization classification as "T-lymphoblastic leukemia/lymphoma." This review gives an overview on the treatment of these aggressive but curable T cell malignancies in adult patients, in order to highlight current ...
Adele Fielding   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy